**Flu hospitalization rates in late August typically hover near or below 0.1 per 100,000 population during the off-season, as influenza transmission remains minimal outside the typical winter peak.** CDC surveillance through late August 2026 shows overall acute respiratory illness activity at very low levels nationally, with influenza-specific metrics suppressed amid rising rhinovirus/enterovirus and some regional COVID-19 increases. Historical FluSurv-NET data from comparable summer weeks, including a 0.1 rate in Week 25 (late June), align with this baseline, while NHSN hospital admission rates for flu have stayed low (around 0.2 or below per 100,000 in recent reports). Trader sentiment reflects this seasonal pattern, with outcomes clustered near 0.1 due to limited early-season signals and the timing just before expected autumn rises. Key variables include any upward shifts in laboratory positivity or ILI outpatient visits in the latest FluView updates, potential early community transmission, or reporting adjustments in RESP-NET data. Resolution hinges on the official weekly rate for Week 34, with model consensus and real-time surveillance providing the primary near-term catalysts.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedFlu Hospitalization Rate Week 34, 2026?
Flu Hospitalization Rate Week 34, 2026?
0.1 52%
<0.1 49%
>0.1 48%
NEW
NEW
Sep 4, 2026
<0.1
49%
0.1
52%
>0.1
48%
0.1 52%
<0.1 49%
>0.1 48%
NEW
NEW
Sep 4, 2026
<0.1
$0 Vol.
49%
0.1
$0 Vol.
52%
>0.1
$0 Vol.
48%
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Flu hospitalization rates in late August typically hover near or below 0.1 per 100,000 population during the off-season, as influenza transmission remains minimal outside the typical winter peak.** CDC surveillance through late August 2026 shows overall acute respiratory illness activity at very low levels nationally, with influenza-specific metrics suppressed amid rising rhinovirus/enterovirus and some regional COVID-19 increases. Historical FluSurv-NET data from comparable summer weeks, including a 0.1 rate in Week 25 (late June), align with this baseline, while NHSN hospital admission rates for flu have stayed low (around 0.2 or below per 100,000 in recent reports).
Trader sentiment reflects this seasonal pattern, with outcomes clustered near 0.1 due to limited early-season signals and the timing just before expected autumn rises. Key variables include any upward shifts in laboratory positivity or ILI outpatient visits in the latest FluView updates, potential early community transmission, or reporting adjustments in RESP-NET data. Resolution hinges on the official weekly rate for Week 34, with model consensus and real-time surveillance providing the primary near-term catalysts.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Market Opened: Aug 28, 2026, 11:04 AM ET
Volume
$0End Date
Sep 4, 2026Market Opened
Aug 28, 2026, 11:04 AM ETResolver
0x69c47De9D...This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Flu hospitalization rates in late August typically hover near or below 0.1 per 100,000 population during the off-season, as influenza transmission remains minimal outside the typical winter peak.** CDC surveillance through late August 2026 shows overall acute respiratory illness activity at very low levels nationally, with influenza-specific metrics suppressed amid rising rhinovirus/enterovirus and some regional COVID-19 increases. Historical FluSurv-NET data from comparable summer weeks, including a 0.1 rate in Week 25 (late June), align with this baseline, while NHSN hospital admission rates for flu have stayed low (around 0.2 or below per 100,000 in recent reports).
Trader sentiment reflects this seasonal pattern, with outcomes clustered near 0.1 due to limited early-season signals and the timing just before expected autumn rises. Key variables include any upward shifts in laboratory positivity or ILI outpatient visits in the latest FluView updates, potential early community transmission, or reporting adjustments in RESP-NET data. Resolution hinges on the official weekly rate for Week 34, with model consensus and real-time surveillance providing the primary near-term catalysts.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$0End Date
Sep 4, 2026Market Opened
Aug 28, 2026, 11:04 AM ETResolver
0x69c47De9D...**Flu hospitalization rates in late August typically hover near or below 0.1 per 100,000 population during the off-season, as influenza transmission remains minimal outside the typical winter peak.** CDC surveillance through late August 2026 shows overall acute respiratory illness activity at very low levels nationally, with influenza-specific metrics suppressed amid rising rhinovirus/enterovirus and some regional COVID-19 increases. Historical FluSurv-NET data from comparable summer weeks, including a 0.1 rate in Week 25 (late June), align with this baseline, while NHSN hospital admission rates for flu have stayed low (around 0.2 or below per 100,000 in recent reports). Trader sentiment reflects this seasonal pattern, with outcomes clustered near 0.1 due to limited early-season signals and the timing just before expected autumn rises. Key variables include any upward shifts in laboratory positivity or ILI outpatient visits in the latest FluView updates, potential early community transmission, or reporting adjustments in RESP-NET data. Resolution hinges on the official weekly rate for Week 34, with model consensus and real-time surveillance providing the primary near-term catalysts.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions